UTHR
USDUnited Therapeutics Corporation Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$432.750
High
$440.000
Low
$430.020
Volume
0.35M
Company Fundamentals
Market Cap
18.8B
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Trading Stats
Avg Volume
0.79M
Exchange
NMS
Currency
USD
52-Week Range
Related News
United Therapeutics Corporation to Present at Upcoming Investor Conferences
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside chat sessions at two upcoming
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
Ongoing EXPAND Study is the First Clinical Trial to Evaluate Xenotransplantation in End-Stage Renal Disease United Therapeutics Corporation (Nasdaq: UTHR) today announced the first clinical xenotransplantation in its
HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $525
HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics with a Buy and raises the price target from $500 to $525.
RBC Capital Maintains Outperform on United Therapeutics, Raises Price Target to $587
RBC Capital analyst Lisa Walter maintains United Therapeutics with a Outperform and raises the price target from $569 to $587.
Wells Fargo Maintains Equal-Weight on United Therapeutics, Raises Price Target to $423
Wells Fargo analyst Benjamin Burnett maintains United Therapeutics with a Equal-Weight and raises the price target from $414 to $423.
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced record financial results for the quarter ended September 30, 2025, driven by continued year-over-year revenue growth in key
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its third quarter 2025 financial results before the market opens on Wednesday, October 29, 2025. A press release detailing the quarterly
Related Stocks
CMSC
CMS Energy Corporation 5.875% Junior Subordinated Notes due 2078
TVGN
Tevogen Bio Holdings Inc.
NE
Noble Corporation plc A Ordinary Shares
ARR
ARMOUR Residential REIT Inc.
MEDS
TRxADE HEALTH Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.